» Articles » PMID: 9334313

K-ras is an Essential Gene in the Mouse with Partial Functional Overlap with N-ras

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 1997 Oct 23
PMID 9334313
Citations 198
Authors
Affiliations
Soon will be listed here.
Abstract

Mammalian ras genes are thought to be critical in the regulation of cellular proliferation and differentiation and are mutated in approximately 30% of all human tumors. However, N-ras and H-ras are nonessential for mouse development. To characterize the normal role of K-ras in growth and development, we have mutated it by gene targeting in the mouse. On an inbred genetic background, embryos homozygous for this mutation die between 12 and 14 days of gestation, with fetal liver defects and evidence of anemia. Thus, K-ras is the only member of the ras gene family essential for mouse embryogenesis. We have also investigated the effect of multiple mutations within the ras gene family. Most animals lacking N-ras function and heterozygous for the K-ras mutation exhibit abnormal hematopoietic development and die between days 10 and 12 of embryogenesis. Thus, partial functional overlap appears to occur within the ras gene family, but K-ras provides a unique and essential function.

Citing Articles

Different Ras isoforms regulate synaptic plasticity in opposite directions.

Lopez-Merino E, Fernandez-Rodrigo A, Jiang J, Gutierrez-Eisman S, Fernandez de Sevilla D, Fernandez-Medarde A EMBO J. 2025; .

PMID: 39984756 DOI: 10.1038/s44318-025-00390-8.


A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer.

Foote J, Mattox T, Keeton A, Chen X, Smith F, Berry K Cancer Res. 2024; 85(5):956-972.

PMID: 39700396 PMC: 11875992. DOI: 10.1158/0008-5472.CAN-24-0323.


"Undruggable KRAS": druggable after all.

Cox A, Der C Genes Dev. 2024; 39(1-2):132-162.

PMID: 39638567 PMC: 11789494. DOI: 10.1101/gad.352081.124.


RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms.

Yang X, Wu H J Hematol Oncol. 2024; 17(1):108.

PMID: 39522047 PMC: 11550559. DOI: 10.1186/s13045-024-01631-9.


Towards Targeting Endothelial Rap1B to Overcome Vascular Immunosuppression in Cancer.

Ghadrdoost Nakhchi B, Kosuru R, Chrzanowska M Int J Mol Sci. 2024; 25(18).

PMID: 39337337 PMC: 11432579. DOI: 10.3390/ijms25189853.


References
1.
Muller R, Slamon D, Adamson E, TREMBLAY J, Muller D, Cline M . Transcription of c-onc genes c-rasKi and c-fms during mouse development. Mol Cell Biol. 1983; 3(6):1062-9. PMC: 368635. DOI: 10.1128/mcb.3.6.1062-1069.1983. View

2.
Glomset J, Farnsworth C . Role of protein modification reactions in programming interactions between ras-related GTPases and cell membranes. Annu Rev Cell Biol. 1994; 10:181-205. DOI: 10.1146/annurev.cb.10.110194.001145. View

3.
Gossler A, Doetschman T, Korn R, Serfling E, Kemler R . Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc Natl Acad Sci U S A. 1986; 83(23):9065-9. PMC: 387075. DOI: 10.1073/pnas.83.23.9065. View

4.
Duffy J, Perrimon N . Recent advances in understanding signal transduction pathways in worms and flies. Curr Opin Cell Biol. 1996; 8(2):231-8. DOI: 10.1016/s0955-0674(96)80070-6. View

5.
Orita S, Kaibuchi K, Kuroda S, Shimizu K, Nakanishi H, Takai Y . Comparison of kinetic properties between two mammalian ras p21 GDP/GTP exchange proteins, ras guanine nucleotide-releasing factor and smg GDP dissociation stimulation. J Biol Chem. 1993; 268(34):25542-6. View